Merck KGaA (MKKGY)

OTCMKTS · Delayed Price · Currency is USD
26.04
0.00 (0.00%)
Nov 24, 2025, 4:00 PM EST
-11.15%
Market Cap56.51B
Revenue (ttm)24.96B
Net Income (ttm)3.47B
Shares Outn/a
EPS (ttm)7.98
PE Ratio16.29
Forward PE13.40
Dividend0.34 (1.30%)
Ex-Dividend DateApr 29, 2025
Volume116,500
Average Volume182,221
Open25.69
Previous Close26.04
Day's Range25.69 - 26.17
52-Week Range24.32 - 31.80
Beta0.73
RSI48.04
Earnings DateNov 13, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables, devices, instruments, software, and services for research, production, and testing; process solutions consisting of filtration devices, chromatography... [Read more]

Sector Healthcare
Founded 1668
Employees 59,020
Stock Exchange OTCMKTS
Ticker Symbol MKKGY
Full Company Profile

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial numbers in EUR Financial Statements

News

Equinix Hosts Merck KGaA's HPC at its Data Center in Germany

EQIX hosts Merck KGaA's new liquid-cooled high-performance computer in Germany, blending private and public cloud to boost scalable, efficient scientific computing.

3 days ago - Nasdaq

Valo Health Partners with Merck KGaA in $3B AI Drug Discovery Deal

Valo Health Partners with Merck KGaA in $3B AI Drug Discovery Deal

4 days ago - GuruFocus

Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal

Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused on Parkinson's and related diseases that is potentially worth over $3 billio...

4 days ago - Reuters

Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson's Disease and Related Disorders

LEXINGTON, Mass.--(BUSINESS WIRE)--Valo Health announces collaboration with Merck KGaA, Darmstadt, Germany to discover and develop novel treatments for Parkinson's and related disorders.

4 days ago - Business Wire

Merck KGaA (MKKGY) Q3 2025 Earnings Call Transcript

Merck KGaA (OTCPK:MKKGY) Q3 2025 Earnings Call November 13, 2025 8:00 AM ESTCompany ParticipantsFlorian Schraeder - Head of Investor RelationsBelén Garijo...

11 days ago - Seeking Alpha

Merck KGaA (MKGAF) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amidst Market Challenges

Merck KGaA (MKGAF) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amidst Market Challenges

11 days ago - GuruFocus

Q3 2025 Merck KGaA Earnings Call Transcript

Q3 2025 Merck KGaA Earnings Call Transcript

11 days ago - GuruFocus

Merck KGaA's Q3 profit rises, beats market view

Merck KGaA reported on Thursday a slight gain in quarterly operating earnings that beat market expectations, benefiting from legislative changes in South America and the sale of a priority review vouc...

12 days ago - Reuters

Dr. Rasha Kelej Meets Senegal First Lady at the Merck Foundation Africa Asia Luminary 2025

Business Wire India Merck Foundation, the philanthropic arm of Merck KGaA Germany, recently conducted the 12th Edition of their annual...

12 days ago - Business Upturn

MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies

Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies Aims to improve researcher access to disease-relevant cell models Strengthens the company’s lea...

27 days ago - Financial Post

Merck KGaA: An AI-Resistant Pharma Play

Discover why Merck KGaA (MKGAF) is undervalued with strong fundamentals, resilient segments, and long-term growth potential.

4 weeks ago - Seeking Alpha

Merck KGaA (MKKGY) Analyst/Investor Day - Slideshow

2025-10-22. The following slide deck was published by Merck KGaA in conjunction with this event.

4 weeks ago - Seeking Alpha

Merck KGaA Reaches Deal With U.S. To Cut Prices On IVF Drugs

(RTTNews) - Merck KGaA (MKKGY) announced that its U.S. and Canadian healthcare division, EMD Serono, has entered into an agreement with President Donald J. Trump's administration to broaden access to ...

5 weeks ago - Nasdaq

Merck KGaA (MKGAF) Offers Major IVF Discount in New US Deal

Merck KGaA (MKGAF) Offers Major IVF Discount in New US Deal

5 weeks ago - GuruFocus

Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs.

President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA, that aims to cut the out-of-pocket costs for in vitro fertilization, with the move com...

5 weeks ago - MarketWatch

Trump announces efforts to expand access to IVF drugs

President Donald Trump announced two new efforts to expand availability of in vitro fertilization, the first concrete step from the Trump administration on the expensive, decades-old procedure. It inc...

5 weeks ago - CNBC

Trump Announces Deal With Germany's Merck on IVF Costs

President Donald Trump announces a deal with Germany's Merck KGaA to cut the price of some of its fertility medicines in exchange for relief from threatened tariffs. He speaks during a a press confere...

5 weeks ago - Bloomberg Markets and Finance

Germany's Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets

The company confirmed its 2025 guidance and is targeting annual organic sales growth in the mid-single-digit percentage range and an expansion in profitability over the medium term.

5 weeks ago - WSJ

Germany's Merck tweaks mid-term healthcare unit guidance

German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on Thursday.

5 weeks ago - Reuters

Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™

Delray Beach, FL,, Oct. 08, 2025 (GLOBE NEWSWIRE) -- formation, and contamination risks threaten sample viability. Ensuring consistent global transportation standards will be a key differentiator for ...

6 weeks ago - Benzinga